Congress orders NIH to study 'Trump Derangement Syndrome' as federal health research.

What it does

This bill directs the National Institutes of Health to conduct or support research into 'Trump Derangement Syndrome' (TDS)—defined as intense emotional or cognitive reactions to Donald Trump—and to report annually to Congress on findings. The bill frames TDS as a public health phenomenon allegedly driven by media coverage and political polarization, and tasks NIH's mental health institutes with studying its origins, effects, and potential interventions.

Why we flagged it

The bill's operative mechanism—directing NIH to research a phenomenon—is straightforward, but the phenomenon itself is defined entirely by reference to one political figure and his opponents' reactions. The framing as a 'syndrome' requiring federal mental-health study, combined with the naming and the congressional reporting requirement, makes this primarily a messaging vehicle rather than a neutral public-health research agenda.

What the text implies

• Annual congressional reporting on research findings about a phenomenon defined by reactions to a sitting political figure embeds that figure's name into federal health research governance and creates a recurring legislative platform for discussing political opposition as a medical condition.
• The bill's definition of TDS as 'intense emotional or cognitive reactions' to Trump's 'actions or public presence' is broad enough to encompass ordinary political disagreement, potentially pathologizing normal democratic opposition.
• Findings section (5) links TDS to assassination attempts against Trump, creating a causal narrative that frames political opposition as connected to violence—a framing that could influence how researchers approach the topic and how Congress interprets findings.
• No new appropriation is stated; the bill directs use of 'existing programs and authorities,' meaning the research agenda is imposed on NIH without dedicated funding, potentially crowding out other mental-health research priorities.

Section numbers refer to the bill text the analysis read — linked under Primary records below.

Who it affects

The bill allocates public research resources to study a phenomenon defined entirely by reference to one political figure's actions and public presence, framing intense political opposition as a psychological disorder requiring federal study. While understanding political polarization and media influence has legitimate public-health value, the bill's naming, framing, and focus on a sitting political figure's opponents as the research subject—rather than polarization itself—raises concerns about u

Named in the bill

National Institutes of Health (NIH), National Institute of Mental Health (NIMH), House Committee on Energy and Commerce, Senate Committee on Health, Education, Labor, and Pensions, Donald J. Trump

Where it stands

1 cosponsor: 1 Republicans.

• May 15, 2025 — Introduced · Congress.gov: “Introduced in House”
• May 15, 2025 — Referred to House Committee on Energy and Commerce · Congress.gov: “Referred to the House Committee on Energy and Commerce”

Dates and quoted wording are Congress.gov's action record; the timeline shows status changes, not every procedural step.

Money around this bill

2 lobbying clients named this bill on 2 disclosure filings across 2 quarters, Dec 2025 to Jun 2026. Those filings disclosed $950,000 in lobbying spend. A filing names 7 bills on average, so that figure is what each filing reported, not a share belonging to this bill.

More lobbying clients named this bill than 41% of bills with at least one filing.

Warren Davidson, the sponsor, reported $281,400 in PAC receipts in the 2026 cycle.

• Neurocrine Biosciences, Inc — $940,000 on 1 filing
• Included Health (formerly Grand Rounds Health) — $10,000 on 1 filing

Lobbying Disclosure Act filings through Jul 20, 2026. A filing shows who paid to lobby on a bill it names, not what changed.